These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
618 related articles for article (PubMed ID: 19156753)
1. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins. Yugawa T; Kiyono T Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753 [TBL] [Abstract][Full Text] [Related]
2. [Molecular basis of cervical carcinogenesis by high-risk human papillomaviruses]. Yugawa T; Kiyono T Uirusu; 2008 Dec; 58(2):141-54. PubMed ID: 19374192 [TBL] [Abstract][Full Text] [Related]
3. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses. Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886 [TBL] [Abstract][Full Text] [Related]
4. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Narisawa-Saito M; Kiyono T Cancer Sci; 2007 Oct; 98(10):1505-11. PubMed ID: 17645777 [TBL] [Abstract][Full Text] [Related]
5. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells. Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029 [TBL] [Abstract][Full Text] [Related]
6. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells. Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212 [TBL] [Abstract][Full Text] [Related]
7. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products. Münger K; Scheffner M; Huibregtse JM; Howley PM Cancer Surv; 1992; 12():197-217. PubMed ID: 1322242 [TBL] [Abstract][Full Text] [Related]
8. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients. de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347 [TBL] [Abstract][Full Text] [Related]
9. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma. Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542 [TBL] [Abstract][Full Text] [Related]
10. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses. Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695 [TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes. Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644 [TBL] [Abstract][Full Text] [Related]
14. Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells. Boulenouar S; Weyn C; Van Noppen M; Moussa Ali M; Favre M; Delvenne PO; Bex F; Noël A; Englert Y; Fontaine V Carcinogenesis; 2010 Mar; 31(3):473-80. PubMed ID: 19917629 [TBL] [Abstract][Full Text] [Related]
15. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells. Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117 [TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer. Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054 [TBL] [Abstract][Full Text] [Related]
17. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions. Cento V; Ciccozzi M; Ronga L; Perno CF; Ciotti M J Med Virol; 2009 Sep; 81(9):1627-34. PubMed ID: 19626616 [TBL] [Abstract][Full Text] [Related]
18. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer. Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681 [TBL] [Abstract][Full Text] [Related]
19. Genomic aberrations of human papillomavirus recovered from cervical cancers. Pao CC; Yao DS; Lin CY; Lee SC; Su HT; Lin SC Biochem Biophys Res Commun; 1996 May; 222(1):116-20. PubMed ID: 8630054 [TBL] [Abstract][Full Text] [Related]
20. [Association between human papillomavirus (HPV) type 16 infection and E6/E7 gene variant and the cervical lesions in Beijing]. Yang YJ; Zhao J; Liao QP Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):32-4. PubMed ID: 17429529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]